Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of October 2019, specifically dated October 9, 2019. The report details a corporate action regarding a capital increase approved by the Board of Directors resulting from the exercise of stock options under the company's Stock Option Plan and Migration Program.
Key Financial Metrics
The filing does not provide financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes and historical stock price data.
Historical Stock Price Data (BRL)
| Period | Lower | Average | Highest |
|---|---|---|---|
| 2018 | 14.70 | 19.25 | 23.58 |
| 2017 | 15.36 | 18.15 | 21.11 |
| 2016 | 14.76 | 17.05 | 18.47 |
| 3Q 2019 | 17.81 | 19.03 | 20.63 |
| 90 Days (as of Oct 2019) | N/A | 19.07 | N/A |
Note: Prices are adjusted to reflect payments of interest on shareholder's equity and dividend distributions.
Material Changes
- Capital Increase: The Board of Directors verified the issuance of new common shares (no par value) on October 9, 2019.
- Source of Issuance: The new shares were issued within the authorized capital limit following the exercise of options by beneficiaries under the Migration Program and the Stock Option Plan approved in July 2013.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is a procedural notice of a capital increase.
Investor Verification Checklist
- Verify the total number of new shares issued and the specific exercise price of the options exercised.
- Confirm the impact of this capital increase on the total authorized and issued share capital.
- Review the full Stock Option Plan and Migration Program terms approved in 2013 for details on vesting and eligibility.
- Check subsequent filings for the updated share count and any dilution effects on earnings per share.